World Number Two tennis player Iga Swiatek's positive test for a little-known product called Trimetazidine raises the issue of whether drug testing is going too far. Should there not be a threshold for the level of prohibited substances found in the body? Is there a performance advantage? What fault lies with the athlete? No matter the final outcome, an athlete remains tainted no matter their potential innocence, which could affect performance and sponsorship agreements. In this Spotlight episode, the team discuss the case, its similarities and differences compared to tennis' other high profile doping case, Janik Sinner, and what it means for anti-doping.
SHOW NOTES:
Join Discourse
If you fancy a bit of the coaching, sports science and sports news conversations with our amazing members, consider a small donation to become a Patron of the site, and get access to our Discourse community, where you can join like-minded fans and sports enthusiasts to keep the conversation going.
The ITA decision statement
BBC story on Swiatek's one-month ban
Swiatek's statement on Instagram
The timeline of Swiatek's doping case
Response from the manufacturer of the drug
Article on Jack Burke's KOMs
When Burke broke the Alp d'Huez KOM
Jack Burke's Strava account
Get bonus content on Patreon
Hosted on Acast. See acast.com/privacy for more information.
